Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Series 3 episode 5. Andrew Lotery and Amanda Stride: Glucokinase MODY – a mildly raised fasting glucose for life that should not be treated

32:38
 
Share
 

Manage episode 452061203 series 3528389
Content provided by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode we talk to Andrew Lotery about how he was found to have a raised fasting glucose on an insurance medical. He was treated as Type 2 diabetes but he questioned this as he was young. slim and physically fit. A chance reading of a research funder’s newsletter led him to the Exeter team and a diagnosis of glucokinase MODY.
Amanda Stride worked as a research registrar in Exeter. She showed that in glucokinase MODY the fasting glucose was raised from birth and remained stable and regulated throughout life with treatment not changing the blood glucose.
Anna Steele showed in her PhD that patients with glucokinase MODY did not get complications affecting the eye or kidney even after 50 years of raised glucose. So in glucokinase MODY treatment with insulin or tablets is not needed and does not work; patients should be discharged and not followed up.

Send us a text

  continue reading

40 episodes

Artwork
iconShare
 
Manage episode 452061203 series 3528389
Content provided by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode we talk to Andrew Lotery about how he was found to have a raised fasting glucose on an insurance medical. He was treated as Type 2 diabetes but he questioned this as he was young. slim and physically fit. A chance reading of a research funder’s newsletter led him to the Exeter team and a diagnosis of glucokinase MODY.
Amanda Stride worked as a research registrar in Exeter. She showed that in glucokinase MODY the fasting glucose was raised from birth and remained stable and regulated throughout life with treatment not changing the blood glucose.
Anna Steele showed in her PhD that patients with glucokinase MODY did not get complications affecting the eye or kidney even after 50 years of raised glucose. So in glucokinase MODY treatment with insulin or tablets is not needed and does not work; patients should be discharged and not followed up.

Send us a text

  continue reading

40 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play